Van Naarden Jacob (CIK 1661254) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-11). Recent activity: Buy LLY (4,866 shares), Buy LLY (4,108 shares), Sell LLY (1,909 shares), Buy LLY (1,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-11 | ELI LILLY & Co (LLY) | EVP,Pres LLY Oncology&HdCorpBD | Buy | 4,866 | $5.1M |
| 2026-02-03 | ELI LILLY & Co (LLY) | EVP,Pres LLY Oncology&HdCorpBD | Buy | 4,108 | $0 |
| 2026-02-03 | ELI LILLY & Co (LLY) | EVP,Pres LLY Oncology&HdCorpBD | Sell | 1,909 | $2.0M |
| 2025-08-13 | ELI LILLY & Co (LLY) | EVP & Pres., Lilly Oncology | Buy | 1,000 | $647,360 |
来源：SEC Form 4 申报文件 · 截至 2026-02-11